vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and Outdoor Holding Co (POWW). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $13.4M, roughly 1.1× Outdoor Holding Co). On growth, Outdoor Holding Co posted the faster year-over-year revenue change (-54.1% vs -69.7%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

Vista Outdoor Inc. was an American designer, manufacturer, and marketer that operated in two segments: shooting sports and outdoor products. It was a "house of brands" with more than 40 labels and subsidiaries.

IRIX vs POWW — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.1× larger
IRIX
$14.7M
$13.4M
POWW
Growing faster (revenue YoY)
POWW
POWW
+15.6% gap
POWW
-54.1%
-69.7%
IRIX

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IRIX
IRIX
POWW
POWW
Revenue
$14.7M
$13.4M
Net Profit
$2.2M
Gross Margin
37.2%
87.1%
Operating Margin
14.7%
Net Margin
16.7%
Revenue YoY
-69.7%
-54.1%
Net Profit YoY
108.5%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
POWW
POWW
Q4 25
$14.7M
$13.4M
Q3 25
$12.5M
$12.0M
Q2 25
$13.6M
$11.9M
Q1 25
$11.9M
$12.6M
Q4 24
$12.7M
$12.5M
Q3 24
$11.6M
$12.0M
Q2 24
$12.6M
$12.3M
Q1 24
$11.8M
$-50.7M
Net Profit
IRIX
IRIX
POWW
POWW
Q4 25
$2.2M
Q3 25
$-1.6M
$1.4M
Q2 25
$-994.0K
$-6.5M
Q1 25
$-1.7M
$-77.5M
Q4 24
$-834.0K
$-26.1M
Q3 24
$-1.9M
$-12.4M
Q2 24
$-2.7M
$-14.8M
Q1 24
$-3.5M
$-5.2M
Gross Margin
IRIX
IRIX
POWW
POWW
Q4 25
37.2%
87.1%
Q3 25
32.1%
87.1%
Q2 25
34.5%
87.2%
Q1 25
42.5%
87.5%
Q4 24
44.0%
87.4%
Q3 24
37.3%
86.9%
Q2 24
40.7%
85.8%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
POWW
POWW
Q4 25
14.7%
Q3 25
-11.3%
5.9%
Q2 25
-6.9%
-50.7%
Q1 25
-1.7%
-213.6%
Q4 24
-3.9%
-163.8%
Q3 24
-16.1%
-50.3%
Q2 24
-20.9%
-50.8%
Q1 24
-28.0%
Net Margin
IRIX
IRIX
POWW
POWW
Q4 25
16.7%
Q3 25
-12.6%
11.7%
Q2 25
-7.3%
-54.5%
Q1 25
-14.2%
-614.5%
Q4 24
-6.6%
-208.7%
Q3 24
-16.7%
-103.7%
Q2 24
-21.2%
-120.2%
Q1 24
-29.5%
10.3%
EPS (diluted)
IRIX
IRIX
POWW
POWW
Q4 25
$0.01
Q3 25
$-0.09
$0.01
Q2 25
$-0.06
$-0.06
Q1 25
$-0.10
$-0.67
Q4 24
$-0.05
$-0.23
Q3 24
$-0.12
$-0.11
Q2 24
$-0.16
$-0.13
Q1 24
$-0.21
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
POWW
POWW
Cash + ST InvestmentsLiquidity on hand
$6.0M
$69.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$237.3M
Total Assets
$29.2M
$271.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
POWW
POWW
Q4 25
$6.0M
$69.9M
Q3 25
$5.6M
$65.7M
Q2 25
$6.8M
$63.4M
Q1 25
$7.2M
$30.2M
Q4 24
$2.4M
$31.9M
Q3 24
$3.9M
$33.5M
Q2 24
$4.1M
$50.8M
Q1 24
$5.4M
$55.6M
Total Debt
IRIX
IRIX
POWW
POWW
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
POWW
POWW
Q4 25
$237.3M
Q3 25
$4.7M
$235.4M
Q2 25
$6.1M
$222.5M
Q1 25
$852.0K
$222.0M
Q4 24
$2.1M
$299.6M
Q3 24
$2.6M
$325.6M
Q2 24
$4.2M
$342.5M
Q1 24
$6.5M
$358.0M
Total Assets
IRIX
IRIX
POWW
POWW
Q4 25
$29.2M
$271.7M
Q3 25
$28.4M
$270.3M
Q2 25
$31.6M
$269.5M
Q1 25
$34.2M
$297.3M
Q4 24
$29.1M
$355.4M
Q3 24
$30.2M
$368.9M
Q2 24
$31.2M
$398.6M
Q1 24
$34.1M
$403.0M
Debt / Equity
IRIX
IRIX
POWW
POWW
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
POWW
POWW
Operating Cash FlowLast quarter
$5.7M
Free Cash FlowOCF − Capex
$5.0M
FCF MarginFCF / Revenue
37.6%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
2.55×
TTM Free Cash FlowTrailing 4 quarters
$-2.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
POWW
POWW
Q4 25
$5.7M
Q3 25
$-1.2M
$3.2M
Q2 25
$-397.0K
$-6.7M
Q1 25
$-1.1M
$-1.5M
Q4 24
$-1.2M
$1.3M
Q3 24
$-3.1M
$-9.3M
Q2 24
$-1.3M
$-547.5K
Q1 24
$-1.6M
$4.3M
Free Cash Flow
IRIX
IRIX
POWW
POWW
Q4 25
$5.0M
Q3 25
$-1.2M
$2.5M
Q2 25
$-410.0K
$-7.6M
Q1 25
$-1.2M
$-2.3M
Q4 24
$-1.2M
$720.3K
Q3 24
$-3.1M
$-10.6M
Q2 24
$-1.3M
Q1 24
$-1.7M
$1.4M
FCF Margin
IRIX
IRIX
POWW
POWW
Q4 25
37.6%
Q3 25
-9.4%
21.0%
Q2 25
-3.0%
-63.8%
Q1 25
-9.8%
-18.6%
Q4 24
-9.8%
5.8%
Q3 24
-26.5%
-88.3%
Q2 24
-11.0%
Q1 24
-14.0%
-2.8%
Capex Intensity
IRIX
IRIX
POWW
POWW
Q4 25
4.8%
Q3 25
0.1%
5.8%
Q2 25
0.1%
7.5%
Q1 25
0.1%
6.5%
Q4 24
0.1%
4.4%
Q3 24
0.0%
10.4%
Q2 24
0.0%
6.5%
Q1 24
0.0%
-5.7%
Cash Conversion
IRIX
IRIX
POWW
POWW
Q4 25
2.55×
Q3 25
2.29×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons